Discover 436 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Edmonton has a research history that most cities cannot match: the first successful islet cell transplant protocol for type 1 diabetes, known worldwide as the Edmonton Protocol, was developed at the University of Alberta in 2000 and changed transplant medicine. Diabetes studies are still a local strength, alongside cancer research at the Cross Cancer Institute, the comprehensive cancer centre for northern Alberta since 1968. Of the roughly 500 studies recruiting in the city, about a third are in oncology, with multiple myeloma and breast cancer among the most common, and the rest span inflammatory bowel disease, pulmonary hypertension, and sleep apnea.
Filter
2
Filter results
Results: 436
Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK
Trial for the Treatment of Acute Asthma in Wheezy Pre-school Aged Children
for
Asthma
Location: Edmonton, Calgary
Sponsor: Janielee Williamson
Sex: All
Age: 1 - 5
Code: NCT01008761
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
for
Methylmalonic Acidemia
Location: Edmonton, Palo Alto CA, Los Angeles CA, San Diego CA,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 1+
Code: NCT05295433
Phase 1, Phase 2, Recruiting
IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment
for
Pediatric Cancer, Pediatric Hematology
Location: Edmonton, Calgary
Sponsor: University of Calgary
Sex: All
Age: 5 - 18
Code: NCT04956133
Recruiting
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
for
Hypochondroplasia
Location: Edmonton, Minneapolis MN, Oakland CA, Milwaukee WI,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 0 - 15
Code: NCT06212947
Recruiting
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Edmonton, Seattle WA, Aurora CO, Palo Alto CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase 2, Phase 3, Recruiting
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
for
Propionic Acidemia
Location: Edmonton, Stanford CA, Los Angeles CA, Chicago IL,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 0+
Code: NCT04159103
Phase 1, Phase 2, Recruiting
WeRoaM: Wearable Remote Monitoring in Heart Failure
for
Heart Failure
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 8 - 18
Code: NCT06969560
Recruiting
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
for
Episodic Migraine
Location: Edmonton, Clinton UT, Bountiful UT, Salt Lake City UT,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05711394
Phase 3, Recruiting
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
for
Achondroplasia
Location: Edmonton, Aurora CO, Madison WI, Torrance CA,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 3 - 10
Code: NCT06842355
Phase 2, Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for
Non-Small Cell Lung Cancer
Location: Edmonton, Seattle WA, Vancouver WA, Portland OR,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT06767514
Phase 3, Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
for
Lysosomal Acid Lipase Deficiency,
Location: Edmonton, Tacoma WA, Minneapolis MN, Stanford CA,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT01633489
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Edmonton, Phoenix AZ, Long Beach CA, San Diego CA,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase 3, Recruiting
Conditioning Electrical Stimulation to Improve Outcomes in Cubital Tunnel Syndrome
for
Cubital Tunnel Syndrome, Electrical Stimulation
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18 - 70+
Code: NCT05395715
Recruiting
Improving Health Outcomes With Kefir
for
Systemic Inflammatory Response, Diabetes Mellitus, Type 2,
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 24 - 70
Code: NCT06695221
Recruiting
The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program
for
Neonatal Abstinence Syndrome
Location: Edmonton
Sponsor: University of Alberta
Sex: Female
Age: 0+
Code: NCT05226624
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease